Dana Lynch
Senior Director, U.S. Communications and Public Relations
Bio:
Dana Lynch is a seasoned communications leader with more than 25 years of experience shaping corporate reputation, guiding C-suite strategy, and leading integrated communications across global pharma, mid-cap biotech and healthcare agencies. She is known for translating complex science into clear, compelling narratives and advising senior leaders across Commercial, R&D, Investor Relations, and Corporate Affairs, with expertise spanning immunology, oncology, rare disease, and cell therapy.
Dana leads U.S. Communications at Ascendis Pharma and has held senior positions at Adaptimmune, Aurinia Pharmaceuticals, and CSL Behring, following more than18 years in various roles on the agency side. Her support of internal and external communications for FDA approvals, product launches, advocacy and disease-awareness campaigns, restructurings, and M&A positioning reflects a deep expertise in strengthening visibility, alignment, and trust for organizations navigating scientific innovation and commercial growth.